# Qwen 3.8 2.4T (A95B) — deep_reasoning/ethical_dilemma_structured

- model_id: `qwen/qwen3.8-2.4t-a95b`
- success: True  | final: 6.78 | quality: 7.5
- latency_total: 20.108s | tokens_per_second: 101.8
- input_tokens: 234 | output_tokens: 2048

## Entrada exacta (lo que recibió el modelo)

**user:**

Una startup de IA tiene un modelo que puede detectar cancer con 95% de precision.
Sin embargo:
- El 5% de falsos positivos causa ansiedad severa y procedimientos innecesarios
- El modelo funciona peor en personas de piel oscura (90% precision vs 97% en piel clara)
- Lanzar ahora salvaria vidas pero con sesgo conocido
- Esperar 6 meses para corregir el sesgo significa que gente morira mientras tanto

El board te pide una recomendacion. Estructura tu analisis:
1. Identifica a todos los stakeholders afectados
2. Analiza los trade-offs cuantitativamente
3. Proporciona 3 opciones con pros/contras de cada una
4. Da tu recomendacion final con justificacion

No busques la respuesta "correcta" - busca la mejor argumentada.


## Respuesta completa

We need answer in Spanish. User asks for structured analysis: stakeholders, quantitative trade-offs, 3 options pros/cons, final recommendation. Ethical dilemma AI cancer detection, 95% precision overall, false positives 5%, worse for dark skin 90 vs 97. Launch now saves lives but bias; wait 6 months means people die. Need best argued, not correct. Need probably carefully reason with assumptions, quantitative examples. Need maybe clarify precision vs sensitivity? The text says precision 95%, false positives 5% maybe implies precision = true positives / (true positives+false positives)=95%, so 5% of positive predictions are false. But in medical context also recall/sensitivity. We need be careful: need base rate, prevalence, number of people screened, disease incidence. We can model with assumed parameters. Need probably discuss fairness metrics, harm mitigation, conditional deployment. Need produce Spanish answer with structured analysis.

Need decide recommendation. Options likely: (1) lanzar completo ahora, (2) esperar 6 months, (3) despliegue escalonado / híbrido con salvaguardas, priorización, human-in-the-loop, monitoring, compensación, calibración, only high-risk groups or as triage, gather data, concurrent validation, maybe use only where clinician shortage, ensure opt-in, transparent. Final recommendation likely phased/regulated deployment now in controlled settings while fixing bias, not blanket launch or full wait. Need justify with expected utility, fairness, autonomy, reciprocity. Need quantify tradeoffs with explicit assumptions. Could use hypothetical cohort of 100,000 screened. Need decide numbers. Let's build model.

Need use terms: precision = positive predictive value? If 95% precision and false positives 5% of positives. We also need sensitivity/recall not given. To estimate lives saved, need true positive detection, mortality reduction. We can make variables: prevalence P, sensitivity S, number needed to screen to_save life, etc. We can present formulas and a worked example.

Maybe assume annual screening: 100,000 personas, prevalence 1% cancer (1,000). Model sensitivity? Not given. Precision by skin group: light 97%, dark 90%. Operationally: among positive predictions, % true cancer. For light precision 97; dark 90. Need false positives. But to know detection, we need positive prediction counts. Could derive from sensitivity and specificity if assume sensitivity equal? But precision differs by prevalence maybe. The prompt says precision poor in dark 90 vs 97 light. Could be PPV difference. If prevalence same, lower precision means more false positives for dark; could be due to lower specificity/sensitivity? Usually bias may be lower sensitivity (miss cancers) and/or lower specificity (more false positives). They only mention false positives causing anxiety and procedures; but lower precision in dark means for every positive, 10% false vs 3%. Also likely misses? We can discuss unknown sensitivity and need measure.

Quantitative trade-offs: If launch now vs wait 6 months. Let deaths prevented = detected cancers earlier * treatability. Need estimate. Maybe assume 100,000 screenings over 6 months, prevalence 0.5% or 1%. Let's choose conservative. For cancer maybe prevalence in screened population 0.5%. If model detects 90% of cancers, delaying 6 months misses chance for some. But model could be used as assist not sole decision.

Need maybe compute false positives by group. Suppose 100,000: 70% light, 30% dark? Or use general. Let's set demographic composition: 60% piel clara, 40% oscura? Could be context dependent. Better present parametric and example. Maybe 100k: 50/50. Prevalence 1%. Need positive rates. Need define PPV and sensitivity. Let's assume sensitivity = 90% for both? But precision varies due to specificity? Let's construct consistent numbers.

PPV = TP/(TP+FP). If prevalence K, sensitivity Se, specificity Sp, PPV = Se*K / (Se*K + (1-Sp)*(1-K)). For K=1%, if PPV=0.95 -> 0.95 = Se*0.01 / (Se*0.01 + (1-Sp)*0.99). If Se=0.90 -> FP contends. 0.95 = 0.009 / (0.009 + FP_rate*0.99) -> denominator=0.0094737 -> FP_rate*0.99=0.0004737 => FP_rate=0.0004785, specificity 99.952%. For PPV=0.90 (dark) with Se=0.90: 0.9 = 0.009 / (0.009+FP*0.99) => denom=0.01, FP*0.99=0.001 => FP_rate=0.001010, specificity 99.899%. If PPV=0.97 light: FP_rate? 0.97=0.009/(0.009+FP*0.99) denom=0.009278, FP*0.99=0.000278 => FP=0.000281, specificity=99.972%. These are plausible. But then overall precision with 50/50 groups? TP=900 total? Light 50k, prev 500, TP=450, FP=50k*0.000281=14.05, PPV=450/464=97%. Dark 50k, prev 500, TP=450, FP=50.5, PPV=89.9%. Total precision=900/(900+64.6)=93.3%, not 95%. Need match overall 95? Maybe group prevalences or sensitivity. But prompt says overall 95, groups 90/97. With equal prevalence and sensitivity, aggregate PPV will be between, average precision weighted by positive counts, about 93.5 if equal predictions. To get overall 95 with 90 and 97, need more positives from light group or different group sizes. Could be skin composition 70% light, 30% dark: positives? Light PPV 97 with many positives, dark 90. Aggregate maybe. If PPV weighted by positives. Suppose positive counts weight w: 0.95 = w*0.97+(1-w)*0.90 => 0.05=0.07w => w=71.4% positives from light. Could be. But not essential. We can state 95 overall masks subgroup.

Maybe simpler: For every 1,000 positive alerts, overall 950 true, 50 false. For dark: 900 true, 100 false; light: 970 true, 30 false. But need number screened. Could create per 10,000 positives. Maybe quantify harms per positive.

Need estimate deaths while waiting. Suppose lanzar evita X deaths by early detection. We can define: let model used in N screenings in 6 months. Let cancer prevalence among screened = 0.5%, sensitivity = 90%, fraction of detected early that reduce mortality = death reduction 20%? If N=100,000, cancers 500; detects 450; early treatment prevents 20% of those deaths = 90 deaths prevented over horizon. Delaying loses perhaps 90 deaths? But not all would be missed; current standard may detect some. Need incremental lives saved vs standard of care. Could say incremental detection over clinician baseline maybe 10% relative improvement. We can model net incremental true positives. Need not overstate.

Alternative: Since no baseline, use variable D = deaths avoided per month. Six months delay costs ~6D. If D > harms from false positives? Need compare death vs anxiety/procedures. Death severe. But fairness also.

Need quantify fairness gap. If light precision 97, dark 90: dark false positive rate per positive alert is 10% vs 3%: 3.33 times higher. If number of positive alerts similar, dark patients bear more unnecessary procedures. Also if lower precision due to false negatives, dark patients miss cancers. Need mention.

Need options:
1. Lanzamiento general inmediato.
Pros: maximize lives saved, rapid learning, incentives. Contras: distributive harm bias, legal/reputational, erosion trust, false positives overload, possibly violates fairness/medical ethics. Could quantify: if 100k screenings, 6-month false positives maybe X, with dark overburdened. Need compute example maybe: N=100,000; 1% prevalence; assume 1,000 cancers; sensitivity? Let's pick numbers easy: For each 10,000 screenings, model flags 100 positives? Hmm.

Maybe use positive alerts: Suppose in 6